, Tracking Stock Market Picks
Enter Symbol:

down 97.67 %

DARA BIOSCIENCES (DARA) rated Buy with price target $1 by C.K. Cooper

Posted on: Thursday,  Feb 11, 2010  9:25 AM ET by C.K. Cooper

C.K. Cooper rated Buy DARA BIOSCIENCES (NASDAQ: DARA) on 02/11/2010, when the stock price was $36.56. Since
then, DARA BIOSCIENCES has lost 97.68% as of 08/27/2015's recent price of $0.85.
If you would have followed this C.K. Cooper's recommendation on DARA, you would have lost 97.67% of your investment in 2023 days.

DARA BioSciences, Inc. (DARA), formerly Point therapeutics, Inc. is a development stage pharmaceutical company that acquires therapeutic molecules and medical technologies from third parties, and advances their clinical development for later sale to pharmaceutical and biotechnology companies. DARA focuses on two drug development programs: KRN5500 for neuropathic pain in cancer patients and DB959 for type 2 diabetes. On February 12, 2008, Point and DARA BioSciences, Inc. completed their merger transaction, in which DP Acquisition Corp. (a wholly owned subsidiary of Point) merged with and into DARA BioSciences, Inc.

C. K. Cooper & Company has for over a decade provided insightful research ideas and commentary. As the firm identifies focus industries it brings together an analytical team to provide unique vision and insight to select investment ideas. In addition, leveraging on the expertise of the firm, the Research Team can evaluate opportunities against a wide database of industry and competitive trends.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/11/2010 9:25 AM Buy
36.56 80.00
as of 12/31/2010
1 Week up  72.00 %
1 Month up  66.81 %
3 Months up  61.92 %
1 YTD up  17.27 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy